Canntab Therapeutics Limited Stock Market Value
| CTABF Stock | USD 0.0001 0.00 0.00% |
| Symbol | Canntab |
Canntab Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Canntab Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Canntab Therapeutics.
| 11/14/2024 |
| 12/14/2024 |
If you would invest 0.00 in Canntab Therapeutics on November 14, 2024 and sell it all today you would earn a total of 0.00 from holding Canntab Therapeutics Limited or generate 0.0% return on investment in Canntab Therapeutics over 30 days. Canntab Therapeutics is related to or competes with Bionoid Pharma, HLS Therapeutics, Crescita Therapeutics, and Avicanna. Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmac... More
Canntab Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Canntab Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Canntab Therapeutics Limited upside and downside potential and time the market with a certain degree of confidence.
Canntab Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Canntab Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Canntab Therapeutics' standard deviation. In reality, there are many statistical measures that can use Canntab Therapeutics historical prices to predict the future Canntab Therapeutics' volatility.Canntab Therapeutics Backtested Returns
We have found three technical indicators for Canntab Therapeutics Limited, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Canntab Therapeutics are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Canntab Therapeutics Limited has no correlation between past and present. Overlapping area represents the amount of predictability between Canntab Therapeutics time series from 14th of November 2024 to 29th of November 2024 and 29th of November 2024 to 14th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Canntab Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Canntab Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Canntab Therapeutics lagged returns against current returns
Autocorrelation, which is Canntab Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Canntab Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Canntab Therapeutics returns to help us make a trade decision. For example, suppose you find that Canntab Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Canntab Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Canntab Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Canntab Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Canntab Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Canntab Therapeutics Lagged Returns
When evaluating Canntab Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Canntab Therapeutics pink sheet have on its future price. Canntab Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Canntab Therapeutics autocorrelation shows the relationship between Canntab Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Canntab Therapeutics Limited.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Canntab Pink Sheet
Canntab Therapeutics financial ratios help investors to determine whether Canntab Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Canntab with respect to the benefits of owning Canntab Therapeutics security.